Sudden Cardiac Death and Arrhythmias.

Sudden cardiac death (SCD) and arrhythmia represent a major worldwide public health problem, accounting for 15-20 % of all deaths. Early resuscitation and defibrillation remains the key to survival, yet its implementation and the access to public defibrillators remains poor, resulting in overall poor survival to patients discharged from hospital. Novel approaches employing smart technology may provide the solution to this dilemma. Though the majority of cases are attributable to coronary artery disease, a thorough search for an underlying cause in cases where the diagnosis is unclear is necessary. This enables better management of arrhythmia recurrence and screening of family members. The majority of cases of SCD occur in patients who do not have traditional risk factors for arrhythmia. New and improved large scale screening tools are required to better predict risk in the wider population who represent the majority of cases of SCD.

[1]  R. Hauer,et al.  Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. , 2012, Journal of the American College of Cardiology.

[2]  G. Kay,et al.  Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. , 2004, Journal of the American College of Cardiology.

[3]  S. Priori,et al.  Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. , 1995, Circulation.

[4]  K. Reinier,et al.  Epidemiology of sudden cardiac death: clinical and research implications. , 2008, Progress in cardiovascular diseases.

[5]  N. Boyle,et al.  Catheter ablation of ventricular tachycardia. , 2010, Circulation.

[6]  A. Skanes,et al.  How to Perform and Interpret Provocative Testing for the Diagnosis of Brugada Syndrome, Long-QT Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia , 2011, Circulation. Arrhythmia and electrophysiology.

[7]  H L Greene,et al.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.

[8]  M. Rosenqvist,et al.  Early cardiopulmonary resuscitation in out-of-hospital cardiac arrest. , 2015, The New England journal of medicine.

[9]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[10]  N. Estes,et al.  Predicting and preventing sudden cardiac death. , 2011, Circulation.

[11]  A. Castellanos,et al.  Indications for implantable cardioverter-defibrillators based on evidence and judgment. , 2009, Journal of the American College of Cardiology.

[12]  S. Petersen,et al.  Diagnosis and Prognosis in Sudden Cardiac Arrest Survivors Without Coronary Artery Disease: Utility of a Clinical Approach Using Cardiac Magnetic Resonance Imaging , 2017, Circulation. Cardiovascular imaging.

[13]  A. Skanes,et al.  Utility of Treadmill Testing in Identification and Genotype Prediction in Long-QT Syndrome , 2010, Circulation. Arrhythmia and electrophysiology.

[14]  Thomas D Rea,et al.  Community approaches to improve resuscitation after out-of-hospital sudden cardiac arrest. , 2010, Circulation.

[15]  J. Healey,et al.  Outcome of Apparently Unexplained Cardiac Arrest: Results From Investigation and Follow-Up of the Prospective Cardiac Arrest Survivors With Preserved Ejection Fraction Registry , 2016, Circulation. Arrhythmia and electrophysiology.

[16]  A. Skanes,et al.  Utility of the recovery electrocardiogram after exercise: a novel indicator for the diagnosis and genotyping of long QT syndrome? , 2010, Heart rhythm.

[17]  Timothy C. Y. Chan,et al.  Optimizing a Drone Network to Deliver Automated External Defibrillators , 2017, Circulation.

[18]  P. Kudenchuk,et al.  Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups. , 1990, Journal of the American College of Cardiology.

[19]  A. Krahn,et al.  Experience with bisoprolol in long-QT1 and long-QT2 syndrome , 2016, Journal of Interventional Cardiac Electrophysiology.

[20]  Hugh Calkins,et al.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.

[21]  A. Wilde,et al.  The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. , 2010, Journal of the American College of Cardiology.

[22]  S. Russell,et al.  Outcomes of Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2012, Circulation. Arrhythmia and electrophysiology.

[23]  J. Healey,et al.  Systematic Assessment of Patients With Unexplained Cardiac Arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER) , 2009, Circulation.

[24]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[25]  P. Schwartz,et al.  Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy. , 2010, Heart rhythm.

[26]  R. Redon,et al.  Clinical Yield of Familial Screening After Sudden Death in Young Subjects: The French Experience , 2017, Circulation. Arrhythmia and electrophysiology.

[27]  T. Aufderheide,et al.  Coronary Artery Disease in Patients With Out-of-Hospital Refractory Ventricular Fibrillation Cardiac Arrest. , 2017, Journal of the American College of Cardiology.

[28]  Hans Eiskjær,et al.  Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. , 2016, The New England journal of medicine.

[29]  X. Jouven,et al.  Emergency Percutaneous Coronary Intervention in Post-Cardiac Arrest Patients Without ST-Segment Elevation Pattern: Insights From the PROCAT II Registry. , 2016, JACC. Cardiovascular interventions.

[30]  A. Wilde,et al.  Long-Term Outcome of Patients Initially Diagnosed With Idiopathic Ventricular Fibrillation: A Descriptive Study , 2016, Circulation. Arrhythmia and electrophysiology.

[31]  O. Franco,et al.  Declining incidence of sudden cardiac death from 1990-2010 in a general middle-aged and elderly population: The Rotterdam Study. , 2015, Heart rhythm.

[32]  P. Kudenchuk,et al.  Impact of Bystander Automated External Defibrillator Use on Survival and Functional Outcomes in Shockable Observed Public Cardiac Arrests , 2018, Circulation.

[33]  B. Gersh,et al.  Sudden cardiac death: epidemiology and risk factors , 2010, Nature Reviews Cardiology.

[34]  P. Lambiase,et al.  Medium-term outcomes of idiopathic ventricular fibrillation survivors and family screening: a multicentre experience , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[35]  C. Tracy,et al.  HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. , 2013, Heart rhythm.

[36]  Riccardo Cappato,et al.  Randomized Comparison of Antiarrhythmic Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Cardiac Arrest The Cardiac Arrest Study Hamburg (CASH) , 2000 .

[37]  S. Szymkiewicz,et al.  Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death , 2016, Circulation.

[38]  S. Viskin,et al.  Efficacy of Quinidine in High-Risk Patients With Brugada Syndrome , 2004, Circulation.

[39]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[40]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[41]  S. Priori,et al.  Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). , 2009, Heart rhythm.

[42]  C. Deakin,et al.  Public access defibrillation remains out of reach for most victims of out-of-hospital sudden cardiac arrest , 2014, Heart.

[43]  K. Aonuma,et al.  Successful catheter ablation of bidirectional ventricular premature contractions triggering ventricular fibrillation in catecholaminergic polymorphic ventricular tachycardia with RyR2 mutation. , 2012, Circulation. Arrhythmia and electrophysiology.

[44]  S. Narayan,et al.  Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study. , 2009, Journal of the American College of Cardiology.

[45]  M. Schalij,et al.  High survival rate of 43% in out-of-hospital cardiac arrest patients in an optimised chain of survival , 2014, Netherlands Heart Journal.

[46]  S M Cobbe,et al.  Surviving out of hospital cardiac arrest at home: a postcode lottery? , 2004, Emergency Medicine Journal.

[47]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[48]  M Gent,et al.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[49]  T. Kawamura,et al.  Outcomes of Out‐of‐Hospital Cardiac Arrest by Public Location in the Public‐Access Defibrillation Era , 2014, Journal of the American Heart Association.

[50]  Tachapong Ngarmukos,et al.  Prevention of Ventricular Fibrillation Episodes in Brugada Syndrome by Catheter Ablation Over the Anterior Right Ventricular Outflow Tract Epicardium , 2011, Circulation.

[51]  A. Moss,et al.  Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease. , 2001, The American journal of cardiology.